241
Participants
Start Date
March 31, 2009
Primary Completion Date
July 31, 2009
Study Completion Date
July 31, 2009
AZD1386
oral, during 4 weeks
AZD1386
oral, during 4 weeks
Placebo
Oral, during 4 weeks
Research Site, Pleven
Research Site, Sofia
Research Site, Bay Roberts
Research Site, St. John's
Research Site, Halifax
Research Site, Brampton
Research Site, Etobicoke
Research Site, Hamilton
Research Site, Newmarket
Research Site, St. Catharines
Research Site, Charlottetown
Research Site, Saint Romuald
Research Site, Sherbrooke
Research Site, Helsinki
Research Site, Hyvinkää
Research Site, Lahti
Research Site, Riihimäki
Research Site, Tampere
Research Site, Vantaa
Research Site, Békéscsaba
Research Site, Budapest
Research Site, Debrecen
Research Site, Miskolc
Research Site, Nyíregyháza
Research Site, Veszprém
Research Site, Japan
Research Site, Bialystok
Research Site, Elblag
Research Site, Gdynia
Research Site, Krakow
Research Site, Lublin
Research Site, Toru
Research Site, Warsaw
Research Site, Brastislava
Research Site, Komárno
Research Site, Liptovský Hrádok
Research Site, Poprad
Research Site, Považská Bystrica
Research Site, Rimavská Sobota
Research Site, Žiar nad Hronom
Research Site, Žilina
Lead Sponsor
AstraZeneca
INDUSTRY